|Day Low/High||92.11 / 95.87|
|52 Wk Low/High||66.93 / 101.73|
A bullish divergence suggests a possible recovery in the near term.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer isn't expecting much action for shares of Cigna while it awaits its acquisition of Express Scripts to close.
David Cordani, president and CEO of health insurance provider Cigna, tells Jim Cramer about the deal for Express Scripts.
This market remains elevated, says Jim Cramer. It's perfectly reasonable to have some selling, but remember: Nobody makes money by panicking.
Stocks closed out the week considerably higher. Here are the top headlines pushing markets further into the green.
'It doesn't rally 10 bucks in one session idly for nothing,' Cramer says.
Jim Cramer says that on Thursday we saw the right stocks rally, even if we didn't see it in the averages. This market had breadth.
As further consolidation in the industry comes back into focus, stocks are teetering.
Merger news, healthcare gains, industrials and even airlines joined the party.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is fond of Cigna's plans to purchase Express Scripts for $67 billion and thinks Cigna shares are a buy.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Express Scripts Holding Company ("Express Scripts" or the "Company") (NASDAQ: ESRX) stock prior...
The union between health insurer Cigna and pharmacy benefit management company Express Scripts Holding will make it easier for customers to access affordable healthcare, said Cigna CEO David Cordani.
Express Scripts shares could open at a two-year high Thursday after Cigna Corp. says it will pay $67 billion, including debt, for the St. Louis-based healthcare benefits manager.
Amazon must move soon to acquire a key healthcare franchise before it misses out completely on rich opportunities or pays too much. Goldman Sachs is scared about markets in 2019.
Remember, Amazon is still a retailer. Don't be so quick to be upset it's not involved in healthcare a lot.
Global stocks rebounded amid speculation that some countries might be exempt from potential U.S. trade tariffs, but China's warning of a "justified" response reminds investors that the spectre of a global trade war has not yet faded.
U.S. stock futures are higher Thursday, as investors react to reports the U.S. may exempt certain countries from its impending trade tariffs; Cigna buys Express Scripts; Snap to lay off engineers.
Are you ready for today's trading? Here's what you need to watch Thursday.
Cigna Corporation (NYSE: CI) and Express Scripts Holding Company (NASDAQ: ESRX) today announced that they have entered into a definitive agreement whereby Cigna will acquire Express Scripts in a cash and stock transaction...
Cigna is reportedly nearing a deal to buy PBM Express Scripts.
Let's see if this near-term price weakness can be followed by renewed gains longer-term.
Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.
Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.
Could Amazon be lost in the jungle when it comes to the drug supply chain? RBC analysts say it's possible. Don't count on a big entrance for at least a few years.
The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.